Blog

One question that we get a lot about CBD and hemp is how to navigate FDA labeling requirements. This is a confusing topic because the FDA hasn’t provided any clear guidance about what is allowed. They’ve only posted some opinions about what is not allowed. The one thing to really avoid in this area is […]

    There is a lot of opportunity in the hemp field and there’s a lot of activity in the space as well. CBD and hemp are derived from the cannabis plant, yet are not psychoactive. They have less than 3/10ths of a percent THC. The federal government has passed some laws that protect CBD […]

Public company ownership in the cannabis industry has become a very important topic of late. In most of the country it is difficult, if not impossible, for public companies to have some sort of ownership stake in a cannabis business, or for a cannabis business to be publicly listed at all. The SEC has allowed […]

The U.S. Drug Enforcement Administration (“DEA”) stated in an internal directive last week that it lacks authority over hemp products that come from the parts of the cannabis plant exempted by the federal Controlled Substances Act (“CSA”). The directive acknowledges that hemp products containing “materials that are made from the cannabis plant and which fall […]

Private equity has been trying to invest in the cannabis industry for some time, but has found some difficulties doing so. In particular because of the structure of private equity. most equity is structured with a handful of general partners. Then dozens if not hundreds of limited partners who hand over their investment to a […]

Mergers and acquisitions in any industry are difficult, but in the cannabis industry, they’re even more so. There are a number of things in mergers and acquisitions that business, buyers, and sellers need to be aware of that they aren’t typically aware of in other industries. Due diligence is important prior to a cannabis transaction. […]

McAllister Garfield, P.C. constantly tracks developments in the California cannabis market to provide our clients with the most up-to-date information that impacts their California cannabis businesses. As such, we have two important updates for California operators: First, if you received your state temporary license on or near January 1, 2018, then your annual application is […]

On Monday, April 9, 2018, the U.S. Food and Drug Administration (“FDA”) published a notice in the Federal Register seeking public comment from interested persons on the scheduling status of cannabis, under international agreements, in a number of forms, including cannabis extracts, THC and CBD. FDA is seeking comments on cannabis to inform the Agency’s […]

On March 21, 2018, Congress extended important existing legal protections for medical marijuana, industrial hemp, and industrial hemp-derived products through September 30, 2018. Congress included these protections in a federal budget bill called the Consolidated Appropriations Act, 2018. You can read the full text of the Act here. Congress will vote on the Act in […]

We are proud to announce that we have added employment lawyer Anne Kelson as one of our California attorneys assisting the Firm and its clients. Anne brings extensive experience in employment counseling and litigation. MAUCRSA and its implementing regulations include many important provisions related to employment law, including mandatory training for employees at infused products […]

This blog discusses how U.S. businesses and entrepreneurs might benefit from the expansion and legalization of cannabis in Canada. Canada has chosen to regulate cannabis at a federal level. This allows Canadian business to both trade their stocks on a public market and export their product(s) both within Canada and internationally. U.S. cannabis businesses and […]